BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• 

  Mergers & acquisitions

  Pharma’s M&A Train Is on Track for Record Highs With More Deals To Come: Analysts

  After a flurry of deals over the past week from Eli Lilly, Merck and Biogen, analysts predict more M&A action from other big names, including Novartis, Amgen and AbbVie.

  April 3, 2026

   · 

  3 min read

   · 

  Annalee Armstrong
• 

  Tariffs

  Trump Hits Drugmakers With 100% Tariff but Carve-outs Soften the Blow

  While some large companies could start paying the full tariff in 120 days, many products, including orphan drugs, cell and gene therapies, and antibody-drug conjugates, will enjoy exemptions that waive or greatly reduce the levies.

  April 3, 2026

   · 

  2 min read

   · 

  Nick Paul Taylor
• 

  Manufacturing

  BioNTech Starts Shuttering Singapore mRNA Manufacturing Site Amid Pipeline Pivot

  BioNTech envisioned the site making hundreds of millions of vaccines a year, but has since shifted its pipeline to other modalities while mRNA technology continues to face headwinds in the U.S.

  April 3, 2026

   · 

  2 min read

   · 

  Nick Paul Taylor
• Press Releases

  BrYet US, Inc. to Present ML-016 Preclinical Efficacy Data at AACR 2026

  Preclinical studies show strong antitumor efficacy in lung metastasis models of triple-negative breast cancer and soft-tissue sarcoma

  April 3, 2026

   · 

  1 min read
• Press Releases

  Relay Therapeutics to Present Initial Clinical Data on Zovegalisib in Vascular Anomalies at the International Society for the Study of Vascular Anomalies World Congress 2026

  April 3, 2026

   · 

  6 min read
• Press Releases

  The University of Colorado Anschutz Gates Institute Achieves First-in-U.S. FDA Clearance for Campus-Built CAR T-Cell Therapy

  April 3, 2026

   · 

  4 min read
• Press Releases

  Aspect Biosystems Announces $280 Million Partnership with Government of Canada to Advance Development of Bioengineered Cellular Medicines

  April 3, 2026

   · 

  3 min read
• Press Releases

  MediWound Reports BARDA Contract Award to Vericel for NexoBrid® Valued at up to $197 Million

  April 3, 2026

   · 

  4 min read
• Press Releases

  Serina Therapeutics Announces NYSE American Acceptance of Continued Listing Compliance Plan

  April 3, 2026

   · 

  3 min read
• Press Releases

  Equillium Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 2, 2026

  April 3, 2026

   · 

  3 min read